Showing results (91-100 of 168) with videos related to
Sort By:
Pageof 17
The Clinical Investigator|March 1, 1994
AIDS-free survival and overall survival in HIV infection: the new CDC classification system (1993) for HIV disease and AIDSB S Kamps, H R Brodt, S Staszewski, et al.The Journal of Antimicrobial Chemotherapy|November 1, 1987
Decrease of caffeine elimination in man during co-administration of 4-quinolonesW Stille, S Harder, S Mieke, et al.Deutsche Medizinische Wochenschrift (1946)|December 9, 1988
[Visceral leishmaniasis (kala-azar) in acquired immunodeficiency syndrome (AIDS)]G Just, R Simader, E B Helm, et al.Drugs|January 1, 1987
Interaction between quinolones and caffeineA H Staib, W Stille, G Dietlein, et al.Deutsche Medizinische Wochenschrift (1946)|August 1, 1986
[Spontaneous course of LAV/HTLV-III infection. Follow-up of persons from AIDS-risk groups]H R Brodt, E B Helm, A Werner, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1990
Demonstration of cross-reactive antibodies able to elicit lysis of both HIV-1- and HIV-2-infected cellsS G Norley, U Mikschy, A Werner, et al.European Journal of Medical Research|November 19, 2002
Limited effect of food composition on the pharmacokinetics of nelfinavir administered twice dailyMichael Kurowski, B Kaeser, A Sawyer, et al.Leukemia Research|March 10, 1999
The effect of sclareol on growth and cell cycle progression of human leukemic cell linesK Dimas, D Kokkinopoulos, C Demetzos, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 11, 2006
Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugsK Dimas, M Papadaki, C Tsimplouli, et al.Immunitat Und Infektion|July 1, 1992
[Enhanced lymphocyte proliferation in the presence of epidermal cells of HIV-infected patients in vitro]R P Kappus, S Berger, C A Thomas, et al.Pageof 17